Literature DB >> 8188368

Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers.

H L Qi1, J Y Tai, M S Blake.   

Abstract

Porins from different neisserial strains and species have been shown to have differences in both primary amino acid sequence and biophysical characteristics as observed by functional assays. A closer examination of how the changes in the primary amino acid sequence of Neisseria porin molecules correlate with these observed biophysical changes has been impeded by the inability to easily manipulate the cloned porin genes by modern molecular techniques and then obtain enough of the expressed modified porin protein to purify and use in these biophysical functional assays. In this report, we describe a method by which the genes encoding three different porin proteins, lacking their neisserial promoter and signal sequences, were cloned into an expression plasmid and transformed into Escherichia coli. Upon induction, large amounts of the porin proteins were produced. The expressed porin proteins were then manipulated to regenerate their native trimer structure and purified by standard protein chemistry. Sufficient purified recombinant porin protein was obtained for further antigenic as well as biophysical characterization. This sets the stage for the biophysical characterization of these neisserial porin proteins in more detail.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188368      PMCID: PMC186529          DOI: 10.1128/iai.62.6.2432-2439.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Studies on gonococcus infection. XIV. Cell wall protein differences among color/opacity colony variants of Neisseria gonorrhoeae.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  A lower size limit exists for export of fragments of an outer membrane protein (OmpA) of Escherichia coli K-12.

Authors:  R Freudl; H Schwarz; M Degen; U Henning
Journal:  J Mol Biol       Date:  1989-02-20       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Purification of outer membrane proteins of the gram-negative bacterium Neisseria gonorrhoeae.

Authors:  R C Judd
Journal:  Anal Biochem       Date:  1988-09       Impact factor: 3.365

5.  Molecular cloning and expression of Neisseria meningitidis class 1 outer membrane protein in Escherichia coli K-12.

Authors:  A K Barlow; J E Heckels; I N Clarke
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

6.  Properties of the major outer membrane protein from Neisseria gonorrhoeae incorporated into model lipid membranes.

Authors:  J D Young; M Blake; A Mauro; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  The surface of Neisseria gonorrhoeae: isolation of the major components of the outer membrane.

Authors:  J E Heckels
Journal:  J Gen Microbiol       Date:  1977-04

10.  Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

View more
  31 in total

1.  Renaturation of recombinant Treponema pallidum rare outer membrane protein 1 into a trimeric, hydrophobic, and porin-active conformation.

Authors:  H H Zhang; D R Blanco; M M Exner; E S Shang; C I Champion; M L Phillips; J N Miller; M A Lovett
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Development of a serological test for Haemophilus ducreyi for seroprevalence studies.

Authors:  C Elkins; K Yi; B Olsen; C Thomas; K Thomas; S Morse
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.

Authors:  K A Jolley; L Appleby; J C Wright; M Christodoulides; J E Heckels
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

5.  Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations.

Authors:  Melanie Olesky; Shuqing Zhao; Robert L Rosenberg; Robert A Nicholas
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

6.  Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.

Authors:  Jennifer R Carmichael; Sukumar Pal; Delia Tifrea; Luis M de la Maza
Journal:  Vaccine       Date:  2011-05-24       Impact factor: 3.641

7.  A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.

Authors:  Chunmei Cheng; Pooja Jain; Ilham Bettahi; Sukumar Pal; Delia Tifrea; Luis M de la Maza
Journal:  Vaccine       Date:  2011-07-08       Impact factor: 3.641

8.  Expression and refolding of Omp38 from Burkholderia pseudomallei and Burkholderia thailandensis, and its function as a diffusion porin.

Authors:  Jaruwan Siritapetawee; Heino Prinz; Chartchai Krittanai; Wipa Suginta
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

9.  Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.

Authors:  Guifeng Sun; Sukumar Pal; Joseph Weiland; Ellena M Peterson; Luis M de la Maza
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

10.  Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.

Authors:  Damiana Chiavolini; Javier Rangel-Moreno; Gretchen Berg; Kate Christian; Laura Oliveira-Nascimento; Susan Weir; Joseph Alroy; Troy D Randall; Lee M Wetzler
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.